Cancel
Nicholas Flytzanis
Founder, Chief Research and Innovation Officer
@
Capsida
1k017qu0.u4897k80e@g91x2be.1kj
Sign up to see email
Known information
- Was a Ph.D. student in the laboratory of Viviana Gradinaru, a Caltech neuroscience professor
- Met Nick Goeden while working in Gradinaru's lab and together envisioned a translational focus for the AAV gene therapy platform
- Co-founded Capsida after developing the concept over lunch at a restaurant named Nick's
About Capsida
Capsida develops targeted, non-invasive intravenous gene therapies for rare and common diseases, with a focus on CNS and ophthalmology disorders.
Report inaccurate information
